CANCER GENETICS, INC 4
4 · CANCER GENETICS, INC · Filed Jun 11, 2015
Insider Transaction Report
Form 4
Chaganti Raju S.K.
Director
Transactions
- Sale
Common Stock, par value $0.0001 per share
2015-06-11$12.05/sh−15,900$191,519→ 137,523 total - Sale
Common Stock, par value $0.0001 per share
2015-06-10$12.03/sh−22,817$274,400→ 153,423 total - Sale
Common Stock, par value $0.0001 per share
2015-06-09$12.01/sh−7,737$92,944→ 176,240 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b-5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were exercised in multiple transactions at prices ranging from $12.00 to $12.05, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares exercised at each separate price within the ranges set forth in footnote (2) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were exercised in multiple transactions at prices ranging from $12.00 to $12.15, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares exercised at each separate price within the ranges set forth in footnote (3) to this Form 4.
- [F4]The price reported in Column 4 is a weighted average price. These shares were exercised in multiple transactions at prices ranging from $12.00 to $12.16, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares exercised at each separate price within the ranges set forth in footnote (4) to this Form 4.